If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

Share Price is delayed by 15 minutes
Get Live Data
128.00    -2.00 (-1.54%)
Bid:
127.50
Ask:
130.00
Spread: 2.50 (1.961%)
Market Cap: £203.93m
RCN Live PriceLast checked at - London Stock Exchange

Intraday Redcentric Share Chart

Issue of Options

1 Jul 2019 15:58

RNS Number : 0912E
Redcentric PLC
01 July 2019
 

 

Redcentric plc ("Redcentric" or the "Company")

 

Issue of Options

 

Redcentric plc (AIM: RCN) announces that on 28 June 2019 it granted a total of 1,241,767 options to executive directors and members of the senior management team to acquire new ordinary shares of 0.1 pence each in the Company under the Company's 2017 Long Term Incentive Plan ("LTIP Options"). The LTIP Options are nil-cost options and subject to continued employment and the meeting of certain performance conditions.

 

The following LTIP Options were granted to Directors:

 

Peter Brotherton, Chief Executive Officer: 379,267.

 

As a result, Peter Brotherton holds 1,061,103 share options in the Company. Mr Brotherton also holds 20,000 ordinary shares in the Company.

 

The notifications below, made in accordance with the requirements of the Market Abuse Regulation, provides further detail.

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Peter Brotherton

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Redcentric plc

b)

Legal Entity Identifier

213800FGYMMNE9OKFD14

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Options to acquire new ordinary shares of 0.1p each

 

 GB00B7TW1V39

 

b)

Nature of the transaction

Grant of options

c)

Currency

GBP

d)

Price(s) and volume(s)

Price

Volume(s)

Nil cost

379,267

 

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

N/A - single transaction

 

 

 

f)

Date of the transaction

28 June 2019

g)

Place of the transaction

Outside of a trading venue

 

 

Enquiries:

Redcentric plc

Peter Brotherton, Chief Executive Officer +44 (0)845 034 111

Harn Jagpal, Company Secretary +44 (0)845034 111

Tulchan

James Macey White / Matt Low +44 (0)20 7353 4200

Numis Securities Limited - Nomad and Joint Broker +44 (0)20 7260 1000

Simon Willis / Oliver Hardy

finnCap Limited - Joint Broker +44 (0)20 7220 0500

Stuart Andrews / Rhys Williams

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHRBMITMBAMBAL
Date   Source Headline
9th Oct 20207:00 amRNSRule 2.9 Announcement
9th Oct 20207:00 amRNSExercise of Options
5th Oct 20207:00 amRNSRule 2.9 Announcement
5th Oct 20207:00 amRNSRestitution Scheme Update
1st Oct 20203:15 pmRNSForm 8.3 - Redcentric PLC
1st Oct 20207:00 amRNSRule 2.9 Announcement
1st Oct 20207:00 amRNSExercise of Options
28th Sep 20202:42 pmRNSForm 8.3 - Redcentric PLC
28th Sep 20207:00 amRNSRule 2.9 Announcement
28th Sep 20207:00 amRNSRestitution Scheme Update
25th Sep 20203:00 pmRNSForm 8.3 - Redcentric PLC
25th Sep 202010:21 amRNSForm 8.3 - Redcentric PLC
24th Sep 20202:49 pmRNSForm 8.3 - Redcentric PLC
23rd Sep 20202:45 pmRNSForm 8.3 - Redcentric PLC
17th Sep 20207:00 amRNSForm 8.3 - Redcentric plc
16th Sep 20202:49 pmRNSResult of AGM
16th Sep 202010:56 amRNSForm 8 (OPD) - SIX DEGREES HOLDINGS LIMITED
14th Sep 202011:30 amRNSRule 2.9 Announcement
14th Sep 202011:30 amRNSRestitution Scheme Update
14th Sep 20208:44 amRNSForm 8.3 - Redcentric Plc
9th Sep 20206:28 pmRNSForm 8.3 - Redcentric PLC
9th Sep 20206:26 pmRNSForm 8.3 - Redcentric PLC
9th Sep 20206:24 pmRNSForm 8.3 - Redcentric PLC
9th Sep 20206:23 pmRNSForm 8.3 - Redcentric PLC
9th Sep 20206:23 pmRNSForm 8.3 - Redcentric PLC
9th Sep 20206:22 pmRNSForm 8.3 - Redcentric PLC
7th Sep 202012:57 pmRNSGranite Growth 169 LLC Form 8.3 - Redcentric Plc
7th Sep 20207:00 amRNSForm 8 (OPD) - Redcentric plc
4th Sep 20204:37 pmRNSForm 8.3 - Redcentric PLC
4th Sep 20209:08 amRNSForm 8.3 - Redcentric Plc
4th Sep 20208:55 amRNSForm 8.3 - Redcentric Plc
3rd Sep 20205:35 pmRNSForm 8.3 - Redcentric Plc
3rd Sep 20204:41 pmRNSSecond Price Monitoring Extn
3rd Sep 20204:35 pmRNSPrice Monitoring Extension
3rd Sep 20204:33 pmRNSForm 8.3 - Redcentric plc
3rd Sep 20201:15 pmRNSForm 8 (OPD) - Redcentric PLC
3rd Sep 202012:00 pmRNSForm 8.5 (EPT/RI) - Redcentric Plc
3rd Sep 20209:07 amRNSForm 8.3 - Redcentric PLC
3rd Sep 20208:30 amRNSRule 2.9 Announcement
2nd Sep 20207:00 amRNSResponse to press speculation-formal sales process
1st Sep 20208:30 amRNSRestitution Scheme Update
1st Sep 20207:00 amRNSSave As You Earn Share Option Scheme
24th Aug 202010:23 amRNSRestitution Scheme Update
17th Aug 20202:45 pmRNSRestitution Scheme Update
11th Aug 20207:00 amRNSPublication of Annual Report and Notice of AGM
11th Aug 20207:00 amRNSRestitution Scheme Update
29th Jul 20207:00 amRNSIssue of Equity and Total Voting Rights
21st Jul 20207:00 amRNSPreliminary Results Announcement FY20
13th Jul 20201:19 pmRNSGeneral Meeting Result, Voting Rights & Admission
26th Jun 202010:07 amRNSAdditional Voting Support

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.